Skip to main content

Table 3 Summary of Respiratory Adverse Events

From: Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial

  

Year 1

Year 2

Year 3

Year 4

Year 5

Number of subjects

BT

45 a

45

43

43

42

 

Control

24a

24

21

-- b

-- b

Number of subjects reporting (Percent of subjects)

BT

38 (84%)

24 (53%)

24 (56%)

23 (53%)

22 (52%)

 

Control

18 (75%)

13 (54%)

12 (57%)

--

--

Events per subject

BT

4.5

1.2

1.3

1.2

1.1

 

Control

3.1

1.2

1.3

--

--

  1. a: Year 1 data only for subjects who enrolled for longer-term follow-up.
  2. b: Control group subjects exited from Study after Year 3 evaluations.